Bart Staels, PhD., is director of the Inserm Unit UMR1011 with laboratories at the Lille Pasteur Institute and Medical Faculty campus.
After his doctorate at the Univ.Leuven, Belgium, he completed his training at the Univ of California in San Francisco and in the BioAvenir Project, Paris.
Other activities: Senior Member of the Institut Universitaire de France (2011-16), co-founder and board member of the European Genomic Institute for Diabetes (EGID, Lille), member of the National Academy of Pharmacy (2011-) and International Francqui Professor Chair (2013). Past-president of the French Atherosclerosis Society (NSFA; 2009-2011).
Awards: the EAS Young Investigator Award, the CNRS Bronze Medal, the Lifetime Achievement Award of the British Atherosclerosis Society, the “Barré” prize from the Faculté de Pharmacie of Montreal (2007), the “JP Binet” prize from the Fondation pour la Recherche Médicale (2011), the “Distinguished Leader in Insulin Resistance” award (ICIR; 2012) and the ICBL Laurens van Deenen award (2017).
B.Staels’ research covers the fields of obesity, diabetes, hepatic and cardiovascular diseases focussing on molecular pharmacology of these cardio-metabolic diseases. He particularly studies the role of nuclear receptors in the control of inflammation and lipid and glucose homeostasis as well as the transcriptional mechanisms involved. B.Staels has published >900 papers (115618 citations; h-index:172).